loading
Axsome Therapeutics Inc stock is traded at $133.94, with a volume of 43,547. It is down -0.70% in the last 24 hours and up +14.54% over the past month. Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
See More
Previous Close:
$134.68
Open:
$133.55
24h Volume:
43,547
Relative Volume:
0.08
Market Cap:
$6.68B
Revenue:
$338.46M
Net Income/Loss:
$-310.96M
P/E Ratio:
-20.51
EPS:
-6.53
Net Cash Flow:
$-132.82M
1W Performance:
+1.79%
1M Performance:
+14.54%
6M Performance:
+24.71%
1Y Performance:
+48.42%
1-Day Range:
Value
$132.61
$134.58
1-Week Range:
Value
$126.80
$134.99
52-Week Range:
Value
$75.56
$139.13

Axsome Therapeutics Inc Stock (AXSM) Company Profile

Name
Name
Axsome Therapeutics Inc
Name
Phone
(212) 332-3241
Name
Address
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Name
Employee
589
Name
Twitter
Name
Next Earnings Date
2025-02-18
Name
Latest SEC Filings
Name
AXSM's Discussions on Twitter

Compare AXSM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
AXSM
Axsome Therapeutics Inc
133.94 6.72B 338.46M -310.96M -132.82M -6.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
419.92 107.73B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
636.56 62.04B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
475.45 62.73B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
833.61 51.09B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
164.92 34.67B 398.11M -1.03B -868.57M -5.7032

Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-01-25 Initiated B. Riley Securities Buy
Sep-03-25 Resumed Wells Fargo Overweight
Jul-03-25 Resumed Morgan Stanley Overweight
Jun-03-25 Initiated Oppenheimer Outperform
Apr-07-25 Initiated Jefferies Buy
Feb-11-25 Initiated Deutsche Bank Buy
Dec-31-24 Reiterated Mizuho Outperform
Sep-03-24 Initiated Wells Fargo Overweight
Aug-06-24 Upgrade BofA Securities Neutral → Buy
Jul-22-24 Initiated Needham Buy
Apr-29-24 Upgrade Morgan Stanley Equal-Weight → Overweight
Mar-19-24 Initiated Robert W. Baird Outperform
Feb-06-24 Initiated UBS Buy
Jan-25-24 Initiated RBC Capital Mkts Outperform
Dec-13-23 Initiated Citigroup Buy
Aug-08-23 Upgrade BofA Securities Underperform → Neutral
Jan-05-23 Initiated Piper Sandler Neutral
Nov-01-22 Initiated Loop Capital Buy
Sep-07-22 Resumed Mizuho Buy
Aug-10-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-10-21 Initiated Berenberg Buy
Jan-08-21 Initiated Jefferies Buy
Dec-16-20 Initiated Mizuho Buy
Sep-29-20 Initiated BofA Securities Underperform
Sep-10-20 Initiated Morgan Stanley Overweight
Apr-28-20 Reiterated H.C. Wainwright Buy
Apr-14-20 Initiated Cowen Outperform
Dec-30-19 Reiterated H.C. Wainwright Buy
Dec-17-19 Reiterated H.C. Wainwright Buy
Dec-16-19 Reiterated Guggenheim Buy
Oct-16-19 Initiated Guggenheim Buy
Sep-18-19 Initiated William Blair Outperform
May-28-19 Initiated SunTrust Buy
May-23-19 Reiterated H.C. Wainwright Buy
Apr-08-19 Initiated SVB Leerink Outperform
Mar-15-19 Reiterated H.C. Wainwright Buy
Oct-03-16 Resumed Brean Capital Buy
Dec-15-15 Initiated Cantor Fitzgerald Buy
Dec-14-15 Initiated Ladenburg Thalmann Buy
View All

Axsome Therapeutics Inc Stock (AXSM) Latest News

pulisher
08:13 AM

How rising interest rates impact Axsome Therapeutics Inc. stockEarnings Miss & Technical Entry and Exit Alerts - newser.com

08:13 AM
pulisher
08:01 AM

Historical volatility pattern of Axsome Therapeutics Inc. visualized2025 Valuation Update & Real-Time Stock Movement Alerts - newser.com

08:01 AM
pulisher
07:30 AM

Can machine learning forecast Axsome Therapeutics Inc. recoveryEarnings Risk Summary & Smart Investment Allocation Insights - newser.com

07:30 AM
pulisher
06:33 AM

Market reaction to Axsome Therapeutics Inc.’s recent news2025 Bull vs Bear & Smart Money Movement Tracker - newser.com

06:33 AM
pulisher
05:47 AM

Peregrine Capital Management LLC Acquires 13,747 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

05:47 AM
pulisher
05:16 AM

Axsome Therapeutics Inc. stock trend forecastInsider Selling & Stock Portfolio Risk Management - newser.com

05:16 AM
pulisher
04:48 AM

How Axsome Therapeutics Inc. stock performs in rate cut cyclesWeekly Investment Summary & Expert Approved Trade Ideas - newser.com

04:48 AM
pulisher
03:54 AM

Has Axsome Therapeutics Inc. formed a bullish divergenceMarket Sentiment Report & Short-Term High Return Strategies - newser.com

03:54 AM
pulisher
03:49 AM

Can Axsome Therapeutics Inc. stock continue upward trendJuly 2025 Setups & Technical Pattern Based Buy Signals - newser.com

03:49 AM
pulisher
03:29 AM

Allianz Asset Management GmbH Increases Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat

03:29 AM
pulisher
02:57 AM

Axsome Therapeutics Inc. stock volume spike explainedJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com

02:57 AM
pulisher
02:52 AM

How Axsome Therapeutics Inc. stock compares to market leaders2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com

02:52 AM
pulisher
02:52 AM

Is Axsome Therapeutics Inc. stock attractive after correctionWeekly Market Outlook & Weekly High Return Stock Opportunities - newser.com

02:52 AM
pulisher
02:05 AM

Is Axsome Therapeutics Inc. stock a buy on dipsJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com

02:05 AM
pulisher
01:52 AM

How supply chain issues affect Axsome Therapeutics Inc. stock2025 Winners & Losers & Weekly Stock Performance Updates - Fundação Cultural do Pará

01:52 AM
pulisher
01:25 AM

How Axsome Therapeutics Inc. (19X) stock reacts to Fed tightening2025 Top Gainers & Smart Allocation Stock Tips - newser.com

01:25 AM
pulisher
12:50 PM

Bull Bear: Is Axsome Therapeutics Inc. stock a top pick in earnings seasonQuarterly Growth Report & Fast Moving Trade Plans - Fundação Cultural do Pará

12:50 PM
pulisher
12:36 PM

Tools to assess Axsome Therapeutics Inc.’s risk profile2025 Winners & Losers & Risk Managed Investment Strategies - newser.com

12:36 PM
pulisher
Oct 27, 2025

Is a relief rally coming for Axsome Therapeutics Inc. holdersCPI Data & Low Volatility Stock Recommendations - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is Axsome Therapeutics Inc. stock gaining market sharePortfolio Risk Summary & Reliable Price Action Trade Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What Wall Street predicts for Axsome Therapeutics Inc. stock priceTrade Performance Summary & Low Volatility Stock Suggestions - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Axsome Therapeutics Advances Study on Solriamfetol for Binge Eating Disorder - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Axsome Therapeutics’ AXS-05 Study: A Potential Game-Changer for MDD Relapse Prevention - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Axsome Therapeutics (AXSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - sharewise.com

Oct 27, 2025
pulisher
Oct 27, 2025

What candlestick patterns are forming on Axsome Therapeutics Inc.Earnings Summary Report & Stepwise Trade Signal Implementation - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is Axsome Therapeutics Inc. forming a reversal patternGold Moves & Low Risk High Reward Ideas - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Axsome Therapeutics (AXSM) Projected to Post Earnings on Monday - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Surprises Report: How rising interest rates impact Axsome Therapeutics Inc. stockJuly 2025 Recap & Fast Moving Market Watchlists - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 05:40:44 - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

2,100 Shares in Axsome Therapeutics, Inc. $AXSM Bought by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat

Oct 27, 2025

Axsome Therapeutics Inc Stock (AXSM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Axsome Therapeutics Inc Stock (AXSM) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
TABUTEAU HERRIOT
Chief Executive Officer
Oct 07 '25
Option Exercise
8.02
13,390
107,388
20,619
TABUTEAU HERRIOT
Chief Executive Officer
Oct 08 '25
Option Exercise
8.02
12,774
102,447
20,003
TABUTEAU HERRIOT
Chief Executive Officer
Oct 06 '25
Sale
120.17
19,220
2,309,667
7,229
TABUTEAU HERRIOT
Chief Executive Officer
Oct 07 '25
Sale
118.77
13,390
1,590,330
7,229
TABUTEAU HERRIOT
Chief Executive Officer
Oct 08 '25
Sale
118.84
12,774
1,518,062
7,229
$36.48
price down icon 2.12%
$85.95
price down icon 7.86%
$28.94
price down icon 0.33%
$105.39
price down icon 0.67%
biotechnology ONC
$313.93
price down icon 0.47%
$165.00
price up icon 0.55%
Cap:     |  Volume (24h):